Skip to main content
The Globe and Mail
Support Quality Journalism
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); }

Can AIDS be cured?

The answer to that question, which until recently many scientists dared not ask out loud, is creeping slowly toward the affirmative, but with some important provisos.

"Cure is an emotional word," said Sharon Lewin, head of the Centre for Biomedical Research at the Burnet Institute in Melbourne, Australia. "Everybody wants to find a cure. It's an aspirational goal."

Story continues below advertisement

But it's also an elusive one.

In the three decades since the AIDS-causing virus HIV was discovered, scientists have learned how to keep it from replicating – with cocktails of antiretroviral drugs – and, as a result, the death rate among people living with HIV-AIDS has dropped precipitously.

But researchers haven't yet figured out how to eradicate the virus from the body completely, which means life-long treatment is required, and that can result in serious side effects, like heart disease, and be costly.

HIV, unlike any other pathogen, seems to have the ability to lie dormant and undetectable in reservoirs.

"Cure means no more virus, and no more treatment," Dr. Lewin said.

Given the ability of the virus to hide, that is unlikely, she said.

But what is possible, and being seen with increasing frequency, is long-term remission, essentially keeping the virus at undetectable levels in the body so it cannot ravage the immune system. But stopping treatment remains risky.

Story continues below advertisement

That became clear in the case of the Mississippi baby. The baby, born HIV-positive, began treatment 31 hours after being born and continued for 18 months. Treatment was discontinued and the virus was undetectable, suggesting she was cured. But after 27 months living seemingly HIV-free, signs of the virus returned, and treatment had to be resumed.

Another intriguing example is the VISCONTI cohort, a group of 14 French patients who were infected between 1996 and 2002, all of whom began treatment within 10 weeks of infection, but subsequently stopped treatment. The virus remained undetectable in their bodies for at least four years, and some are still virus-free after more than a decade.

That's long-term remission, but is it a cure?

Then there are the "Canadian babies," five children who began treatment with antiretroviral drugs shortly after birth. After the case of the Mississippi baby made headlines, researchers looked back and found four of them showed no signs of HIV, between two and eight years later, though they are continuing treatment; the fifth baby stopped treatment and the virus re-appeared.

To date, only one patient out of the 78 million who have been infected HIV is believed to have been cured in the true sense of the word – permanently.

Timothy Ray Brown, better known as the Berlin patient, was diagnosed with HIV in 1995 and then with leukemia in 2006. He was treated with a bone marrow transplant from a person with something called a CCR5 receptor mutation, a rare genetic anomaly that makes people naturally resistant to HIV. Mr. Brown essentially got a new, supercharged immune system, stopped treatment for HIV and has been HIV-free for the eight years since. (He did, however, suffer a second bout of leukemia and needed another transplant.)

Story continues below advertisement

What is not often discussed is that the treatment that cured Mr. Brown almost killed him and left him disabled, and at least two other patients who underwent the same treatment died.

Still, the notion of rebuilding the immune system is intriguing, if not practical on a large scale. At least four other patients, two in Boston and two in Sydney, all of whom had leukemia, have been "cured" this way.

In the Boston patients, however, HIV returned to detectable levels three and seven months after the transplant. The virus remains undetectable in the Sydney cases, but they have not stopped antiretroviral treatment.

"The ethics of a possible HIV cure are complex," said Dr. Jintanat Ananworanich, associate director of the U.S. Military HIV Research Program in Bethesda, Md.

To know whether a patient has been cured, treatment has to be discontinued, which can put their life at risk; the best candidates for research are therefore healthy, and not the most in need; and the cost of finding a cure is enormous, which may divert funds from other prevention and treatment efforts.

Still, scientists have learned a couple of important lessons from these unusual cases: Treating people as soon as possible after infection is important, and they need better tools to find the virus because "undetectable" does not mean it is gone.

Story continues below advertisement

What researchers are trying now is a "kick and kill approach." They are trying to kick the virus out of its hiding place and then kill it.

One of the most discussed papers at last month's 20th International AIDS Conference in Melbourne was by a group of Danish researchers who used a cancer drug, romidepsin, to lure HIV out of reservoirs before blasting it with high doses of drugs. Unfortunately, there was still virus left behind, meaning a cure remains elusive.

"Many very smart people don't think a cure is possible or will ever be possible," said Steven Deeks, a researcher with the Positive Health Program (AIDS Program) at San Francisco General Hospital.

"My personal opinion is that if it is possible, and we can do it, it's going to take many, many years."

And then, Dr. Deeks said, will come an even larger dilemma: Will the cure be affordable and accessible to all?

Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies